Description:
China Medical Technologies, Inc. (China Medical) is a People’s Republic of China-based medical device company, which develops, manufactures and markets advanced immunodiagnostic and molecular diagnostic products utilizing enhanced chemiluminescence immunoassay (ECLIA) technology, fluorescent in situ hybridization (FISH) technology and surface plasmon resonance (SPR) technology. The in-vitro diagnostics (IVD) products are used to detect and monitor various diseases and disorders through laboratory evaluation and analysis of blood, urine or other body fluids. The Company operates in two business segments: immunodiagnostic systems and molecular diagnostic systems. Immunodiagnostic systems include ECLIA analyzers and reagent kits. The molecular diagnostic systems include FISH imaging analyzers and probes. It also includes SPR systems and human papillomavirus- deoxyribonucleic acid (HPV-DNA) chips. The wholly owned subsidiary of the Company is CMED ECLIA Diagnostic Technology Ltd.

Officers and Directors:
Xiaodong Wu Chairman of the Board, Chief Executive Officer
Age: 53

Takyung Tsang Chief Financial Officer, Director
Age: 38

Feng Zhu Vice President - Business Development and Investor Relations
Age: 40

Zhong Chen Chief Technology Officer
Age: 44

Iain Ferguson Bruce Independent Director
Age: 69

Lawrence A. Crum Independent Director
Age: 68

Guoming Qi Independent Director
Age: 63

Yuedong Li Independent Director

Contact:
No. 24 Yong Chang North Road Beijing Tech. Development Area
Beijing, BEJ 100176
China
+86-10-65308833 (Phone)
+86-10-65309733 (Fax)